Analyses for abnormality of cell cycle regulator molecules and their application to diagnosis and therapy in bone and soft tissue tumors
Analyses for abnormality of cell cycle regulator molecules and their application to diagnosis and therapy in bone and soft tissue tumors
批准号:
14570161
负责人:
DOBASHI Yoh
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have previously reported several diverse functions of cell cycle regulator molecules. In this research project, more detailed analysis was performed using cultured cells as well as human surgical materials of osteosarcoma in comparison to those of lung carcinomas. And, we clarified the followings.i) Overexpression of cyclin D1 or ccdk4, which cause apoptosis in neuronal cultured cells, also caused apoptosis in osteosarcoma and in other cultured cells (Anticancer Res. 2003, Curr. Medic. Chem. 2003).ii) Furthermore, apoptosis induced by overexpression of cyclin D1/cdk4 was observed in human tumors, such as lung carcinomas (Int. J. Cancer 2004).iii) The protein levels of cyclins/cdks were diversely regulated not only by their expression, but also by degradation system, depending on the histological types. In lung carcinoma, cyclin A is highly expressed in proliferating cells and rapidly degraded. However, cyclin E, specifically in squamous cell carcinoma, is accumulated as kinase-inactive-form without degradation in proteasome system (J. Pathol. 2003).iv) Epidermal growth factor receptor (EGFR) is overexpressed in 7 to 15% of the cases in carcinomas of gastrointestinal tract, and overexpression is predominantly caused by gene amplification (Mod. Pathol. 2004).v) Overexpression of EGFR was observed in 2% of bone and soft tissue sarcomas, and those cases were exclusively associated with gene abnormality, i.e., amplification and polysomy (manuscript submitted).
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Dobashi, Y., et al.: "Diversity in expression and prognostic significance of G1/S cyclins in human primary lung carcinomas."Journal of Pathology. 199(2). 208-220 (2003)
Dobashi, Y. 等人:“人原发性肺癌中 G1/S 细胞周期蛋白的表达多样性及其预后意义。”病理学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Dobashi, Y., et al.: "Overexpression of Cdk4/Cyclin D1, a possible mediator of apoptosis and an indicator of prognosis in human primary lung Carcinomas."International Journal of Cancer. (In press).
Dobashi, Y. 等人:“Cdk4/Cyclin D1 的过度表达,可能是细胞凋亡的介质,也是人原发性肺癌预后的指标。”国际癌症杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sakurai, H, Dobashi, Y, Mizutani, E, Matsubara, H., Suzuki, S, Takano, K, Shindo, S, Matsumoto, M.: "Bronchioloalveolar carcinoma of the lung 3 cm or less in diameter : A prognostic assessment."Ann Thorac Surg. (In Press).
Sakurai, H, Dobashi, Y, Mizutani, E, Matsubara, H., Suzuki, S, Takano, K, Shindo, S, Matsumoto, M.:“直径 3 厘米或以下的细支气管肺泡癌:预后评估
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Dobashi, Y., et al.: "Overexpression of Cdk4/Cyclin D1, a possible mediator of apoptosis and an indicator of prognosis in human primary lung Carcinomas."International Journal of Cancer. 110(4). 532-541 (2004)
Dobashi, Y. 等人:“Cdk4/Cyclin D1 的过度表达,可能是细胞凋亡的介质,也是人原发性肺癌预后的指标。”国际癌症杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Dobashi, Y., et al.: "Perspectives for Cancer Therapy : "Cell Cycle Blockers and Perturbators""Current Medicinal Chemistry. (In press).
Dobashi, Y. 等人:“癌症治疗的展望:“细胞周期阻断剂和扰动剂”“当前药物化学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 15 条
Involvement of Akt/mTOR in lung cancer and design of novel therapy targeting them
-
批准号:26460438
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2014
-
负责人:DOBASHI Yoh
-
依托单位:
Aberrant activations of cellular kinases and exploration of novel targeted therapy in human solid cancers
-
批准号:23590409
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2011
-
负责人:DOBASHI Yoh
-
依托单位:
Activation of signal transduction pathway by aberration of oncogenes : comprehensive analysis and application for multi-molecular targeting therapy
-
批准号:20590351
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2008
-
负责人:DOBASHI Yoh
-
依托单位:
Aberrant activation of signal transduction pathways regulating cell proliieration in human slid tumors. Molecular-pathological analysis and clinical application of molecular targeting therapy.
-
批准号:18590327
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.47万
-
财政年份:2006
-
负责人:DOBASHI Yoh
-
依托单位:
Investigation of abnomatily of cell cycle regulation and its clinical application in human lung cancer
-
批准号:11670191
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:1999
-
负责人:DOBASHI Yoh
-
依托单位:
海外基金